Global Nonsteroidal Antiinflammatory Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Nonsteroidal Antiinflammatory Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune diseases and pain diseases.
Nonsteroidal Antiinflammatory Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nonsteroidal Antiinflammatory Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Osteoarthritis and Muscle Aches are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nonsteroidal Antiinflammatory Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nonsteroidal Antiinflammatory Drugs key manufacturers include Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer and DOMESCO, etc. Sanofi S.A., Novartis AG, GlaxoSmithKline PLC are top 3 players and held % sales share in total in 2022.
Nonsteroidal Antiinflammatory Drugs can be divided into Oral Nonsteroidal Antiinflammatory Drugs and Injection Nonsteroidal Antiinflammatory Drugs, etc. Oral Nonsteroidal Antiinflammatory Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Nonsteroidal Antiinflammatory Drugs is widely used in various fields, such as Osteoarthritis, Muscle Aches, Backaches and Dental Pain, etc. Osteoarthritis provides greatest supports to the Nonsteroidal Antiinflammatory Drugs industry development. In 2022, global % sales of Nonsteroidal Antiinflammatory Drugs went into Osteoarthritis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nonsteroidal Antiinflammatory Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi S.A.
Novartis AG
GlaxoSmithKline PLC
Pfizer
DOMESCO
Segment by Type
Oral Nonsteroidal Antiinflammatory Drugs
Injection Nonsteroidal Antiinflammatory Drugs
Osteoarthritis
Muscle Aches
Backaches
Dental Pain
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Nonsteroidal Antiinflammatory Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nonsteroidal Antiinflammatory Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nonsteroidal Antiinflammatory Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Nonsteroidal Antiinflammatory Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nonsteroidal Antiinflammatory Drugs introduction, etc. Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Nonsteroidal Antiinflammatory Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Nonsteroidal Antiinflammatory Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nonsteroidal Antiinflammatory Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Osteoarthritis and Muscle Aches are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nonsteroidal Antiinflammatory Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nonsteroidal Antiinflammatory Drugs key manufacturers include Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer and DOMESCO, etc. Sanofi S.A., Novartis AG, GlaxoSmithKline PLC are top 3 players and held % sales share in total in 2022.
Nonsteroidal Antiinflammatory Drugs can be divided into Oral Nonsteroidal Antiinflammatory Drugs and Injection Nonsteroidal Antiinflammatory Drugs, etc. Oral Nonsteroidal Antiinflammatory Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Nonsteroidal Antiinflammatory Drugs is widely used in various fields, such as Osteoarthritis, Muscle Aches, Backaches and Dental Pain, etc. Osteoarthritis provides greatest supports to the Nonsteroidal Antiinflammatory Drugs industry development. In 2022, global % sales of Nonsteroidal Antiinflammatory Drugs went into Osteoarthritis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nonsteroidal Antiinflammatory Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi S.A.
Novartis AG
GlaxoSmithKline PLC
Pfizer
DOMESCO
Segment by Type
Oral Nonsteroidal Antiinflammatory Drugs
Injection Nonsteroidal Antiinflammatory Drugs
Segment by Application
Osteoarthritis
Muscle Aches
Backaches
Dental Pain
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Nonsteroidal Antiinflammatory Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nonsteroidal Antiinflammatory Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nonsteroidal Antiinflammatory Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Nonsteroidal Antiinflammatory Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nonsteroidal Antiinflammatory Drugs introduction, etc. Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Nonsteroidal Antiinflammatory Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices